| 4.82 0 (0%) | 06-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.12 | 1-year : | 7.14 |
| Resists | First : | 5.23 | Second : | 6.12 |
| Pivot price | 4.89 | |||
| Supports | First : | 4.63 | Second : | 4.25 |
| MAs | MA(5) : | 4.9  |
MA(20) : | 4.85  |
| MA(100) : | 5.05 |
MA(250) : | 6 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 30.3 |
D(3) : | 42.2 |
| RSI | RSI(14): 50.3 | |||
| 52-week | High : | 9.32 | Low : | 4.01 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SRTS ] has closed above bottom band by 34.8%. Bollinger Bands are 62.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 65 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.03 - 5.06 | 5.06 - 5.08 |
| Low: | 4.69 - 4.72 | 4.72 - 4.76 |
| Close: | 4.76 - 4.82 | 4.82 - 4.87 |
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Mon, 16 Jun 2025
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2025 Earnings Call Transcript - MSN
Thu, 12 Jun 2025
Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views? - MSN
Tue, 10 Jun 2025
Investing in Sensus Healthcare (NASDAQ:SRTS) five years ago would have delivered you a 71% gain - Yahoo Finance
Fri, 16 May 2025
Sensus Healthcare Inc (SRTS) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Thu, 15 May 2025
Earnings call transcript: Sensus Healthcare misses Q1 2025 EPS forecast, stock dips - Investing.com
Thu, 15 May 2025
Sensus Healthcare Reports First Quarter 2025 Financial Results - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 16.9 (%) |
| Held by Institutions | 25.9 (%) |
| Shares Short | 909 (K) |
| Shares Short P.Month | 875 (K) |
| EPS | 0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.57 |
| Profit Margin | 4.5 % |
| Operating Margin | 40.8 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | 3.4 % |
| Qtrly Rev. Growth | 155.6 % |
| Gross Profit (p.s.) | 1.34 |
| Sales Per Share | 2.4 |
| EBITDA (p.s.) | 0.17 |
| Qtrly Earnings Growth | 433.2 % |
| Operating Cash Flow | 5 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | 43.81 |
| PEG Ratio | 0 |
| Price to Book value | 3.07 |
| Price to Sales | 2 |
| Price to Cash Flow | 16.94 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|